Sign In

Login

Password

Forgot Password ? Sign Up

Lysosomal storage disease (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Lysosomal storage disease" in English language version.

refsWebsite
Global rank English rank
17nih.gov
4th place
4th place
10doi.org
2nd place
2nd place
6worldcat.org
5th place
5th place
4semanticscholar.org
11th place
8th place
1nature.com
234th place
397th place
1archive.org
6th place
6th place
1medscape.com
719th place
636th place
1gaucherdisease.org
low place
low place

archive.org

doi.org

  • Platt, Frances M.; d'Azzo, Alessandra; Davidson, Beverly L.; Neufeld, Elizabeth F.; Tifft, Cynthia J. (2018-10-01). "Lysosomal storage diseases". Nature Reviews Disease Primers. 4 (1): 27. doi:10.1038/s41572-018-0025-4. ISSN 2056-676X. PMID 30275469. S2CID 52896843.
  • Winchester B, Vellodi A, Young E (2000). "The molecular basis of lysosomal storage diseases and their treatment". Biochem. Soc. Trans. 28 (2): 150–4. doi:10.1042/bst0280150. PMID 10816117.
  • Meikle, P. J.; Hopwood, J. J.; Clague, A. E.; Carey, W. F. (20 January 1999). "Prevalence of lysosomal storage disorders". JAMA. 281 (3): 249–254. doi:10.1001/jama.281.3.249. ISSN 0098-7484. PMID 9918480. S2CID 14297661.
  • Navarrete-Martínez, Juana Inés; Limón-Rojas, Ana Elena; Gaytán-García, Maria de Jesús; Reyna-Figueroa, Jesús; Wakida-Kusunoki, Guillermo; Delgado-Calvillo, Ma. del Rocío; Cantú-Reyna, Consuelo; Cruz-Camino, Héctor; Cervantes-Barragán, David Eduardo (May 2017). "Newborn screening for six lysosomal storage disorders in a cohort of Mexican patients: Three-year findings from a screening program in a closed Mexican health system". Molecular Genetics and Metabolism. 121 (1): 16–21. doi:10.1016/j.ymgme.2017.03.001. PMID 28302345.
  • Clarke JT, Iwanochko RM (2005). "Enzyme replacement therapy of Fabry disease". Mol. Neurobiol. 32 (1): 043–050. doi:10.1385/MN:32:1:043. PMID 16077182. S2CID 24240533.
  • Nagree, Murtaza S.; Scalia, Simone; McKillop, William M.; Medin, Jeffrey A. (2019-07-03). "An update on gene therapy for lysosomal storage disorders". Expert Opinion on Biological Therapy. 19 (7): 655–670. doi:10.1080/14712598.2019.1607837. ISSN 1471-2598. PMID 31056978. S2CID 145822883.
  • Ponder KP, Haskins ME (2007). "Gene therapy for mucopolysaccharidosis". Expert Opin Biol Ther. 7 (9): 1333–1345. doi:10.1517/14712598.7.9.1333. PMC 3340574. PMID 17727324.
  • McNeill, Alisdair; Magalhaes, Joana; Shen, Chengguo; Chau, Kai-Yin; Hughes, Derralyn; Mehta, Atul; Foltynie, Tom; Cooper, J. Mark; Abramov, Andrey Y. (2014-05-01). "Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells". Brain. 137 (5): 1481–1495. doi:10.1093/brain/awu020. ISSN 0006-8950. PMC 3999713. PMID 24574503.
  • Albin, Roger L.; Dauer, William T. (2014-05-01). "Magic shotgun for Parkinson's disease?". Brain. 137 (5): 1274–1275. doi:10.1093/brain/awu076. ISSN 0006-8950. PMID 24771397.
  • Fois, Giorgio; Hobi, Nina; Felder, Edward; Ziegler, Andreas; Miklavc, Pika; Walther, Paul; Radermacher, Peter; Haller, Thomas; Dietl, Paul (2015). "A new role for an old drug: Ambroxol triggers lysosomal exocytosis via pH-dependent Ca2+ release from acidic Ca2+ stores". Cell Calcium. 58 (6): 628–637. doi:10.1016/j.ceca.2015.10.002. PMID 26560688.

gaucherdisease.org

medscape.com

emedicine.medscape.com

nature.com

  • Platt, Frances M.; d'Azzo, Alessandra; Davidson, Beverly L.; Neufeld, Elizabeth F.; Tifft, Cynthia J. (2018-10-01). "Lysosomal storage diseases". Nature Reviews Disease Primers. 4 (1): 27. doi:10.1038/s41572-018-0025-4. ISSN 2056-676X. PMID 30275469. S2CID 52896843.

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Platt, Frances M.; d'Azzo, Alessandra; Davidson, Beverly L.; Neufeld, Elizabeth F.; Tifft, Cynthia J. (2018-10-01). "Lysosomal storage diseases". Nature Reviews Disease Primers. 4 (1): 27. doi:10.1038/s41572-018-0025-4. ISSN 2056-676X. PMID 30275469. S2CID 52896843.
  • Winchester B, Vellodi A, Young E (2000). "The molecular basis of lysosomal storage diseases and their treatment". Biochem. Soc. Trans. 28 (2): 150–4. doi:10.1042/bst0280150. PMID 10816117.
  • Meikle, P. J.; Hopwood, J. J.; Clague, A. E.; Carey, W. F. (20 January 1999). "Prevalence of lysosomal storage disorders". JAMA. 281 (3): 249–254. doi:10.1001/jama.281.3.249. ISSN 0098-7484. PMID 9918480. S2CID 14297661.
  • M, Fuller; PJ, Meikle; JJ, Hopwood (2006). "2. Epidemiology of lysosomal storage diseases: an overview". Fabry Disease: Perspectives from 5 Years of FOS. Oxford PharmaGenesis. ISBN 1-903539-03-X. PMID 21290699. NBK11603.
  • Navarrete-Martínez, Juana Inés; Limón-Rojas, Ana Elena; Gaytán-García, Maria de Jesús; Reyna-Figueroa, Jesús; Wakida-Kusunoki, Guillermo; Delgado-Calvillo, Ma. del Rocío; Cantú-Reyna, Consuelo; Cruz-Camino, Héctor; Cervantes-Barragán, David Eduardo (May 2017). "Newborn screening for six lysosomal storage disorders in a cohort of Mexican patients: Three-year findings from a screening program in a closed Mexican health system". Molecular Genetics and Metabolism. 121 (1): 16–21. doi:10.1016/j.ymgme.2017.03.001. PMID 28302345.
  • Clarke JT, Iwanochko RM (2005). "Enzyme replacement therapy of Fabry disease". Mol. Neurobiol. 32 (1): 043–050. doi:10.1385/MN:32:1:043. PMID 16077182. S2CID 24240533.
  • Bruni S, Loschi L, Incerti C, Gabrielli O, Coppa GV (2007). "Update on treatment of lysosomal storage diseases". Acta Myol. 26 (1): 87–92. PMC 2949325. PMID 17915580.
  • Nagree, Murtaza S.; Scalia, Simone; McKillop, William M.; Medin, Jeffrey A. (2019-07-03). "An update on gene therapy for lysosomal storage disorders". Expert Opinion on Biological Therapy. 19 (7): 655–670. doi:10.1080/14712598.2019.1607837. ISSN 1471-2598. PMID 31056978. S2CID 145822883.
  • Ponder KP, Haskins ME (2007). "Gene therapy for mucopolysaccharidosis". Expert Opin Biol Ther. 7 (9): 1333–1345. doi:10.1517/14712598.7.9.1333. PMC 3340574. PMID 17727324.
  • McNeill, Alisdair; Magalhaes, Joana; Shen, Chengguo; Chau, Kai-Yin; Hughes, Derralyn; Mehta, Atul; Foltynie, Tom; Cooper, J. Mark; Abramov, Andrey Y. (2014-05-01). "Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells". Brain. 137 (5): 1481–1495. doi:10.1093/brain/awu020. ISSN 0006-8950. PMC 3999713. PMID 24574503.
  • Albin, Roger L.; Dauer, William T. (2014-05-01). "Magic shotgun for Parkinson's disease?". Brain. 137 (5): 1274–1275. doi:10.1093/brain/awu076. ISSN 0006-8950. PMID 24771397.
  • Fois, Giorgio; Hobi, Nina; Felder, Edward; Ziegler, Andreas; Miklavc, Pika; Walther, Paul; Radermacher, Peter; Haller, Thomas; Dietl, Paul (2015). "A new role for an old drug: Ambroxol triggers lysosomal exocytosis via pH-dependent Ca2+ release from acidic Ca2+ stores". Cell Calcium. 58 (6): 628–637. doi:10.1016/j.ceca.2015.10.002. PMID 26560688.

ncbi.nlm.nih.gov

ghr.nlm.nih.gov

semanticscholar.org

api.semanticscholar.org

  • Platt, Frances M.; d'Azzo, Alessandra; Davidson, Beverly L.; Neufeld, Elizabeth F.; Tifft, Cynthia J. (2018-10-01). "Lysosomal storage diseases". Nature Reviews Disease Primers. 4 (1): 27. doi:10.1038/s41572-018-0025-4. ISSN 2056-676X. PMID 30275469. S2CID 52896843.
  • Meikle, P. J.; Hopwood, J. J.; Clague, A. E.; Carey, W. F. (20 January 1999). "Prevalence of lysosomal storage disorders". JAMA. 281 (3): 249–254. doi:10.1001/jama.281.3.249. ISSN 0098-7484. PMID 9918480. S2CID 14297661.
  • Clarke JT, Iwanochko RM (2005). "Enzyme replacement therapy of Fabry disease". Mol. Neurobiol. 32 (1): 043–050. doi:10.1385/MN:32:1:043. PMID 16077182. S2CID 24240533.
  • Nagree, Murtaza S.; Scalia, Simone; McKillop, William M.; Medin, Jeffrey A. (2019-07-03). "An update on gene therapy for lysosomal storage disorders". Expert Opinion on Biological Therapy. 19 (7): 655–670. doi:10.1080/14712598.2019.1607837. ISSN 1471-2598. PMID 31056978. S2CID 145822883.

worldcat.org

search.worldcat.org

  • Platt, Frances M.; d'Azzo, Alessandra; Davidson, Beverly L.; Neufeld, Elizabeth F.; Tifft, Cynthia J. (2018-10-01). "Lysosomal storage diseases". Nature Reviews Disease Primers. 4 (1): 27. doi:10.1038/s41572-018-0025-4. ISSN 2056-676X. PMID 30275469. S2CID 52896843.
  • Meikle, P. J.; Hopwood, J. J.; Clague, A. E.; Carey, W. F. (20 January 1999). "Prevalence of lysosomal storage disorders". JAMA. 281 (3): 249–254. doi:10.1001/jama.281.3.249. ISSN 0098-7484. PMID 9918480. S2CID 14297661.
  • Boron, W.; Boulpaep, E., eds. (2012). Medical Physiology (2nd ed.). Saunders Press. ISBN 978-1-4377-1753-2. OCLC 1083396596.
  • Nagree, Murtaza S.; Scalia, Simone; McKillop, William M.; Medin, Jeffrey A. (2019-07-03). "An update on gene therapy for lysosomal storage disorders". Expert Opinion on Biological Therapy. 19 (7): 655–670. doi:10.1080/14712598.2019.1607837. ISSN 1471-2598. PMID 31056978. S2CID 145822883.
  • McNeill, Alisdair; Magalhaes, Joana; Shen, Chengguo; Chau, Kai-Yin; Hughes, Derralyn; Mehta, Atul; Foltynie, Tom; Cooper, J. Mark; Abramov, Andrey Y. (2014-05-01). "Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells". Brain. 137 (5): 1481–1495. doi:10.1093/brain/awu020. ISSN 0006-8950. PMC 3999713. PMID 24574503.
  • Albin, Roger L.; Dauer, William T. (2014-05-01). "Magic shotgun for Parkinson's disease?". Brain. 137 (5): 1274–1275. doi:10.1093/brain/awu076. ISSN 0006-8950. PMID 24771397.